Funded Tech Companies

EpilepsyGTx

Wondering who backed EpilepsyGTx? HTH VC and UCL Technology Fund joined the equity holders in this life sciences company.

Company Overview

Company Name
EpilepsyGTx
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds

Contact Information

Mailing Address
Building 1000 Cambridge Research Park Beach Drive
Waterbeach Cambridgeshire, CB25 9PD
UK
Email Address

Company Background Information

Overview
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE). Focal epilepsy describes a group of disorders in which patients experience seizures that arise from a specific part of the brain1. Refractory epilepsy occurs when seizures persist despite trials of at least two tolerated and appropriately chosen antiseizure medicines2.
Profile
EpilepsyGTx LinkedIn Company Profile
Social Media
EpilepsyGTx Company Twitter Account
Company News
EpilepsyGTx News
Facebook
EpilepsyGTx on Facebook
YouTube
EpilepsyGTx on YouTube
Last Transaction
6/24/2024

Financing History

Date
Type
Amount
Venture Equity
$10,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Nicolas Koebel
  Nicolas Koebel LinkedIn Profile  Nicolas Koebel Twitter Account  Nicolas Koebel News  Nicolas Koebel on Facebook
Chief Scientific Officer
Dimitri Kullmann
  Dimitri Kullmann LinkedIn Profile  Dimitri Kullmann Twitter Account  Dimitri Kullmann News  Dimitri Kullmann on Facebook
VP - R & D
Luiz Silva
  Luiz Silva LinkedIn Profile  Luiz Silva Twitter Account  Luiz Silva News  Luiz Silva on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Epigenomics AG | Epilot

 

Share this article

 


About Our VC Transaction Database

Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary